LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model-based approach
Neil C. Barnes (London, United Kingdom), Salman H. Siddiqui, Ian Pavord, Neil C. Barnes, Sally Lettis, Alessandro Guasconi, Stefano Petruzzelli
|  |
Dose modifications and dose intensity during treatment with pirfenidone
Steven Nathan (Falls Church, United States of America), Steven Nathan, Lisa Lancaster, Carlo Albera, Marilyn Glassberg, Jeffrey Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Ute Petzinger, Paul Noble
|  |
Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies
Steven Nathan (Falls Church, United States of America), Steven Nathan, Carlo Albera, Ulrich Costabel, Ian Glaspole, Marilyn Glassberg, Lisa Lancaster, David Lederer, Carlos Pereira, Jeffrey Swigris, Andrey Pavlov, John Stauffer, Bann-Mo Day, Willis Chou, Athol Wells
|  |
Protective effects of vitamin D supplementation against acute respiratory infection are greatest in those with the lowest baseline vitamin D status
Adrian R Martineau (London, United Kingdom), Adrian R. Martineau, David A. Jolliffe, Richard L. Hooper, Lauren Greenberg, John F. Aloia, Peter Bergman, Gal Dubnov-Raz, Susanna Esposito, Davaasambuu Ganmaa, Emma C. Goodall, Cameron Grant, Christopher J. Griffiths, Wim Janssens, Ilkka Laaksi, Semira Manaseki-Holland, David Murdoch, Rachel E. Neale, Judy R. Rees, Steve Simpson, Iwona Stelmach, Geeta Trilok Kumar, Mitsuyoshi Urashima, Carlos A. Camargo
| |
Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency
Helmut Teschler (Essen, Germany), Helmut Teschler, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit, N. Gerard McElvaney
| |
Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A1-PI) deficiency following treatment with A1-PI
Noel Gerard McElvaney (Dublin, Ireland), Noel Gerard McElvaney, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit
| |
Effectiveness of rituximab (RTX) therapy in recurrent granulomatosis with polyangiitis (GPA)
Dariusz Gawryluk (Warsaw, Poland), Dariusz Gawryluk, Justyna Fijolek, Elzbieta Wiatr
| |
Combination of pentoxifylline and vitamin E for the treatment of sarcoidosis: Retrospective analysis
Alexander Vizel (Kazan, Republic of Tatarstan, Russian Federation), Alexander Vizel, Irina Vizel
| |